Hikma Pharmaceuticals Share News (HIK)

London midday: Stocks higher after China exports fall less than forecast

(ShareCast News) - London stocks were sitting higher after a better-than-expected report on Chinese exports lifted sentiment. China's exports dropped 5.5% in August from a year earlier in dollar terms after a 8.3% drop in July, according to the General Administration of Customs, better than the 6.6%

TOP NEWS SUMMARY: Insurance M&A Continues As Mitsui Sumitomo Buys Amlin

Hikma Pharmaceuticals inks deal to buy Egypt-based EIMC United

(ShareCast News) - Hikma Pharmaceuticals has agreed to acquire almost the entire share capital of Egypt-based EIMC United Pharmaceuticals (EUP) from a consortium of shareholders for an undisclosed sum. EUP is a pharmaceutical manufacturing company specialising in oncology products and Hikma said the

UPDATE 1-Hikma says to buy Egyptian pharma firm EIMC United

(Adds details, background, share movement) Sept 8 (Reuters) - Hikma Pharmaceutical Plc said it would buy nearly the entire share capital of EIMC United Pharmaceuticals, a drugmaker specialising in oncology products, from a consortium of shareholders to boost its position in the Egyptian mar

LONDON BRIEFING: Amlin Agrees To Be Bought By Mitsui Sumitomo Insurance

LONDON MARKET PRE-OPEN: Stocks To Open Firm As Amlin Agrees Takeover

Hikma says to buy Egyptian pharma firm EIMC United

Sept 8 (Reuters) - Hikma Pharmaceutical Plc said it would buy nearly the entire share capital of EIMC United Pharmaceuticals, a drugmaker specialising in oncology products, from a consortium of shareholders to strengthen its position in the Egyptian market. Hikma, which makes and markets br

Hikma Pharmaceuticals Strikes Deal To Buy Egypt's EIMC United

London close: Equities drop after worse-than-forecast non-farms

(ShareCast News) - Equities in the UK market ended lower on Friday after the US non-farm payrolls report missed forecasts. American employers added 173,000 jobs in August following an upwardly revised 245,000 in July, data released on Friday by the Labor Department showed. The figure was the smalle

LONDON MARKET CLOSE: Stocks Weak As Fed Decision Remains Uncertain

Broker tips: Hikma Pharmaceuticals, BP, GKN

(ShareCast News) - Goldman Sachs upgraded Hikma Pharmaceuticals to 'buy' from 'neutral', added the stock to its regional stock 'focus list' and lifted its price target to 2,840p from 2,210p. "We see the acquisition of Roxane Labs as the realisation of large transformational M&A that we had expected

FTSE 100 movers: Hikma nudges up on Goldman upgrade, miners slide

(ShareCast News) - London's top-flight index was down 2.2% to 6,059.90 at 1515 BST, extending earlier losses following a weaker-than-expected US nonfarm payrolls report. Hikma Pharmaceuticals nudged a little higher after Goldman Sachs upgraded the stock to 'buy' from 'neutral' and lifted its price t

Goldman Sachs upgrades Hikma on Roxane Labs acquisition

(ShareCast News) - Goldman Sachs upgraded Hikma Pharmaceuticals to 'buy' from 'neutral', added the stock to its regional stock 'focus list' and lifted its price target to 2,840p from 2,210p. "We see the acquisition of Roxane Labs as the realisation of large transformational M&A that we had expected

BROKER RATINGS SUMMARY: Exane BNP Cuts Next, Raises Kingfisher

LONDON MARKET OPEN: Investors Cautious Ahead Of US Jobs Report